Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
ASPC manual of preventive cardiology / / Nathan D. Wong, Ezra A. Amsterdam, Peter P. Toth, editors
| ASPC manual of preventive cardiology / / Nathan D. Wong, Ezra A. Amsterdam, Peter P. Toth, editors |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Humana Press, , [2021] |
| Descrizione fisica | 1 online resource (XIX, 761 p.) |
| Disciplina | 616.12 |
| Collana | Contemporary cardiology |
| Soggetto topico |
Cardiology
Health promotion Primary care (Medicine) |
| ISBN | 3-030-56279-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter. 1: Focus on Cardiovascular Health Promotion and Disease Prevention- Opportunities for Improvement -- Chapter. 2: National and Global Trends of Cardiovascular Disease Mortality, Morbidity, and Risk -- Chapter. 3: Cardiovascular Risk Assessment: From Global Risk Scoring to Risk Enhancing Factors -- Chapter. 4: Assessment and Management of Psychosocial Risk Factors within Preventive Cardiology Practice -- Chapter. 5: Dietary Strategies for Atherosclerotic Cardiovascular Risk Reduction -- Chapter. 6: Physical Activity Strategies -- Chapter. 7: Obesity Management and Prevention of Cardiovascular Disease -- Chapter. 8: Smoking and Vaping -- Chapter. 9: Alcohol and Cardiovascular Diseases -- Chapter. 10: The 2018 AHA/ACC/Multi-Society Cholesterol guidelines: A personalized approach to risk reduction -- Chapter. 11: Blood Pressure and Hypertension Management -- Chapter. 12: Cardiodiabetology: Reducing Risks to Optimize Cardiovascular Disease Outcomes -- Chapter. 13: Antiplatelet Therapy -- Chapter. 14: Inflammation and Atherosclerotic Cardiovascular Disease -- Chapter. 15: The Role of Genetics in Preventive Cardiology: Utility of Clinically Available Genetic Tests -- Chapter. 16: Exercise Electrocardiographic Stress Testing -- Chapter. 17: Ultrasound and MRI Assessment of Cardiovascular Risk -- Chapter. 18: Role of CT Coronary Calcium Scanning and Angiography in Evaluation of Cardiovascular Risk -- Chapter. 19: Cardiovascular Disease Prevention in Women -- Chapter. 20: Racial/Ethnic Considerations in the Prevention of Cardiovascular Disease -- Chapter. 21: Prevention of Heart Failure -- Chapter. 22: Prevention of Peripheral Arterial Disease -- Chapter. 23: Prevention of Atrial Fibrillation -- Chapter. 24: Prevention of Ischemic Stroke -- Chapter. 25: Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease -- Chapter. 26: Primary Prevention of Cardiovascular Disease Guidelines -- Chapter. 27: Secondary Prevention and Cardiac Rehabilitation -- Chapter. 28: Integrative Approaches for Cardiovascular Disease Prevention -- Chapter. 29: Preventive Cardiology as Specialized Medical Art. . |
| Record Nr. | UNINA-9910484352203321 |
| Cham, Switzerland : , : Humana Press, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Lipoprotein(a) / / edited by Karam Kostner, Gerhard M. Kostner, and Peter P. Toth
| Lipoprotein(a) / / edited by Karam Kostner, Gerhard M. Kostner, and Peter P. Toth |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Humana, , [2023] |
| Descrizione fisica | 1 online resource (446 pages) |
| Disciplina | 371 |
| Collana | Contemporary cardiology (Totowa, N.J.) |
| Soggetto topico | Lipoprotein A |
| ISBN | 3-031-24575-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 60 years of Lp(a) research-From Ouchterlonys double diffusion to a significant risk factor for CHD -- Lp(a) structure and composition -- Genetics of Lipoprotein(a) -- Lp(a) metabolism -- Contemporary aspects of Lp(a) metabolism and therapies based on tracer kinetic methods -- Role of Proprotein Convertase Subtilisin Kexin type 9 in Lipoprotein(a) Metabolism -- The Role of Cell Surface Receptors in Lp(a) Metabolism -- Physiological Roles And Functions Of Lipoprotein(a) -- The role of Lp(a) in Atherosclerosis: An overview -- Role of macrophages in Lp(a) pathophysiology -- Thrombosis, Inflammation and Lipoprotein(a): Clinical Implications -- The role of the kidney in Lp(a) physiology and pathophysiology -- Lp(a) as a cardiovascular risk factor -- Lp(a) and aortic valve stenosis, stroke, and other non-coronary cardiovascular diseases -- Lp(a) in cardiovascular disease: Evidence from Large Epidemiological Studies -- Lipoprotein(A) And Immunity -- When to measure Lp(a) -- Measurement of Lipoprotein (a) in the Clinical Laboratory -- Standardization of analytical methods for the measurement of Lipoprotein(a): bridging past and future initiatives -- Establishing an SI-traceable Reference Measurement System for Lp(a), based on Quantitative Protein Mass Spectrometry and Molar Units -- Compounds that impact Lp(a) concentrations -- Antisense oligonucleotide therapy to treat elevated lipoprotein(a) -- Lipoprotein apheresis for reduction of Lipoprotein(a) -- Elevated Lp(a) - Why Should I Test For It, If I Cannot Treat It? A Patient’s Perspective -- Burning unanswered questions Therapy. |
| Record Nr. | UNINA-9910678261303321 |
| Cham, Switzerland : , : Humana, , [2023] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Therapeutic lipidology / / Michael H. Davidson, Peter P. Toth and Kevin C. Maki (editors)
| Therapeutic lipidology / / Michael H. Davidson, Peter P. Toth and Kevin C. Maki (editors) |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (XV, 689 p. 140 illus., 114 illus. in color.) |
| Disciplina | 616.399706 |
| Collana | Contemporary Cardiology |
| Soggetto topico |
Cardiology
Endocrinology Chemotherapy |
| ISBN | 3-030-56514-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. History of Lipidology -- Chapter 2. Atherogenesis and Vascular Biology -- Chapter 3. Genetic Disorders of Lipoprotein Metabolism -- Chapter 4. Cardiovascular Genomics -- Chapter 5. Epidemiology of Atherosclerotic Cardiovascular Disease -- Chapter 6. Comparison of 2018 AHA-ACC Multi-Society Cholesterol Guidelines with 2013 ACC-AHA Cholesterol Guidelines -- Chapter 7. The Low-Density Lipoprotein Cholesterol Hypothesis: An Update -- Chapter 8. Triglyceride-rich Lipoprotein Cholesterol (Remnant Cholesterol) as a Therapeutic Target for Cardiovascular Disease Risk -- Chapter 9. Medical Nutrition Therapy for Lipid and Lipoprotein Disorders -- Chapter 10. Nutraceuticals and Lipid Management -- Chapter 11. Pharmacology of Statins -- Chapter 12. Management of Statin Intolerance -- Chapter 13. Intestinally Active Therapies for Hypercholesterolemia: Ezetimibe, Bile Acid Resins and Plant Sterols -- Chapter 14. Proprotein Convertase Subtilisin/Kexin Type 9: Functional Role in Lipid Metabolism and its Therapeutic Inhibition -- Chapter 15. Management of Hypertriglyceridemia (Including Fibrates and n-3 Fatty Acids) -- Chapter 16. Pathophysiology and Management of Dyslipidemias Associated with Insulin-resistant States -- Chapter 17. Therapeutic Management of Obesity -- Chapter 18. High Density Lipoproteins -- Chapter 19. Lipoprotein (a): Principles from Bench to Bedside -- Chapter 20. Management of Homozygous Familial Hypercholesterolemia -- Chapter 21. Lysosomal Acid Lipase Deficiency -- Chapter 22. Lipodystrophies -- Chapter 23. HIV and Dyslipidemia -- Chapter 24. Cardiovascular Disease in Women: Focus on Lipid Management -- Chapter 25. Management of Dyslipidemia in the Elderly -- Chapter 26. Management of Dyslipidemia in Children -- Chapter 27. Lipoprotein Subfractions in Clinical Practice -- Chapter 28. Ion Mobility Lipoprotein Analysis -- Chapter 29. How ApoB Measurements Could Improve Prevention of Cardiovascular Disease -- Chapter 30. C-reactive Protein and Other Inflammatory Markers in Cardiovascular Disease; Inflammatory Disorders and Atherosclerosis -- Chapter 31. Coronary Artery Calcium and CT Angiography -- Chapter 32. The Clinical Use of Ultrasound for Atherosclerosis Imaging -- Chapter 33. Emerging Therapies for Regulating Dyslipidemias and Atherosclerosis -- Chapter 34. The Allied Health Professional’s Role in the Management of Dyslipidemia and Accreditation Council for Clinical Lipidology Certification Program -- Chapter 35. The American Board of Clinical Lipidology Physician Certification Program. |
| Record Nr. | UNINA-9910484983203321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||